Company advancing Brilacidin as a next-generationbroad-spectrum antiviral forthe treatment of common colds and deadly coronavirusinfections WAKEFIELD, Mass., Nov. 30, 2020 (GLOBE NEWSWIRE) -- ...
Hospitals and health systems across the country are focused on their response to the coronavirus pandemic. In hot spots like Seattle or New York City, hospital CEOs are already in the midst of ...
Nirmatrelvir–ritonavir (Paxlovid [Pfizer]) is used as first-line therapy for nonhospitalized persons with Covid-19 1 on the basis of the results of the Evaluation of Protease Inhibition for Covid-19 ...
Putting together the “Innovationeering” series has made me refresh — and occasionally reconstruct — my legacy thinking about the practice of innovation. What has also emerged is the reminder that one ...
With limited vaccine manufacturing capacity around the world, South Africa will have to prioritise its own requirements in the interest of securing access to a vaccine as a matter of national security ...
Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...
From HIV/AIDS to Covid-19, global health emergencies have revived calls for compulsory licensing. But history shows that ...
COVID-19 is a respiratory disease. Yet, from the earliest days of the pandemic, the cardiovascular risks associated with SARS-CoV-2 infection were clear: individuals with severe cases of COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results